Grasso Global

The iShares Biotechnology ETF (NASDAQ: IBB), which includes several large cap biotechs, has recently narrowed its year-to-date loss to around 10%. On CNBC’s “Halftime Report Final Trades,” Jeffrey Mills of Bryn Mawr Trust recommended going long on biotech stocks. Check out...